Ann Wiegand

The virology Core at the HIV Drug Resistance Program, NCI-Frederick

Affiliated withNCI-Frederick

Research Area

Immunology and Infection

Biography

Ann Wiegand has not added Biography.
If you are Ann Wiegand and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 10	2011

Other Publications

Article	Year
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet\| PubMed ID: 16099290	2005
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. Journal of clinical microbiology\| PubMed ID: 14532178	2003
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS pathogens\| PubMed ID: 17411338	2007
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18332425	2008
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS (London, England)\| PubMed ID: 18525258	2008
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity\| PubMed ID: 19062316	2008
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. The Journal of infectious diseases\| PubMed ID: 19191590	2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. The Journal of infectious diseases\| PubMed ID: 19432547	2009
Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. The Journal of infectious diseases\| PubMed ID: 19656066	2009
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients. The Journal of infectious diseases\| PubMed ID: 20102272	2010
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PloS one\| PubMed ID: 20186346	2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS medicine\| PubMed ID: 20711481	2010
HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. Journal of virology\| PubMed ID: 20926564	2010
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating ... Journal of virology\| PubMed ID: 21367910	2011
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral Therapy. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 22083073	2012
Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques. Journal of virology\| PubMed ID: 22238316	2012